Sign up to save your podcasts
Or
Share NRG-BR008, The "HERO" Breast Cancer Trial
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NRG-BR008, The "HERO" Breast Cancer Trial
The NRG Oncology Podcast Co-hosts sit with NRG-BR008 "HERO" Study Co-PIs Dr. Lior Braunstein and Dr. Melissa Mitchell to discuss this study for low-risk HER2+ breast cancer. This study will test if HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation for patients with early-stage HER2+ breast cancer.
View all episodes
By NRG Oncology
5
77 ratings
The NRG Oncology Podcast Co-hosts sit with NRG-BR008 "HERO" Study Co-PIs Dr. Lior Braunstein and Dr. Melissa Mitchell to discuss this study for low-risk HER2+ breast cancer. This study will test if HER2-targeted therapy without radiation therapy is as good as the usual treatment of HER2-targeted therapy with radiation for patients with early-stage HER2+ breast cancer.
More shows like The NRG Oncology Podcast
View all
NEJM This Week
325 Listeners
ASTRO Journals
37 Listeners
ASCO Daily News
58 Listeners
The Daily
111,917 Listeners
Up First from NPR
56,277 Listeners
Suze Orman's Women & Money (And Everyone Smart Enough To Listen)
4,421 Listeners
Naval
2,098 Listeners
The Journal.
5,950 Listeners
QuadShot News Podcast
62 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
9,236 Listeners
Two Onc Docs
169 Listeners
At The Beam
31 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
39 Listeners
Value Health Voices
5 Listeners